(Q67796033)
Statements
Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis (English)
Pharmacokinetics and Dose Response after Intravenous and Subcutaneous Administration of Recombinant Erythropoietin in Patients on Regular Haemodialysis Treatment or Continuous Ambulatory Peritoneal Dialysis (English)
1 reference
F. Stockenhuber
U. Loibl
M. Gottsauner-Wolf
C. Jahn
W. Manker
T. F. Meisl
1 January 1991